| 1929 |
Increased incidence of cardiovascular morbidity and mortality in the general population
Short Name
Increased incidence of cardiovascular morbidity and mortality
|
0 |
Population |
Aug 21, 2021 |
Aug 21, 2021 |
519: Cardiac ion channels blockade leading to increased incidence of cardiovascular morbidity and mortality
|
| 1932 |
Gastrointestinal disorders
Short Name
GI disorders
|
0 |
Individual |
Sep 2, 2021 |
Sep 8, 2021 |
None
|
| 1933 |
Increased, Interleukin-6 production
Short Name
Increased IL-6 production
|
0 |
Cellular |
Sep 20, 2021 |
Sep 20, 2021 |
416: Aryl hydrocarbon receptor activation leading to lung cancer through IL-6 toxicity pathway
|
| 1934 |
Myocardial Infarction
Short Name
Heart attack
|
0 |
Organ |
Oct 15, 2021 |
Oct 15, 2021 |
426: SARS-CoV-2 spike protein binding to ACE2 receptors expressed on pericytes leads to endothelial cell dysfunction, microvascular injury and myocardial infarction.
|
| 1935 |
Angiotensin (1-7) levels diminished
Short Name
Ang (1-7) levels reduced
|
0 |
Molecular |
Oct 15, 2021 |
Oct 15, 2021 |
427: ACE2 downregulation following SARS-CoV-2 infection triggers dysregulation of RAAS and can lead to heart failure.
|
| 1936 |
Angiotensin II degradation reduced
Short Name
Degradation of Ang-II reduced
|
0 |
Molecular |
Oct 17, 2021 |
Oct 17, 2021 |
427: ACE2 downregulation following SARS-CoV-2 infection triggers dysregulation of RAAS and can lead to heart failure.
|
| 1937 |
ADAM17 expression induction
Short Name
ADAM17 induction
|
0 |
Cellular |
Oct 17, 2021 |
Oct 17, 2021 |
427: ACE2 downregulation following SARS-CoV-2 infection triggers dysregulation of RAAS and can lead to heart failure.
|
| 1938 |
ACE2 increased shedding
Short Name
ACE2 increased shedding
|
0 |
Molecular |
Oct 17, 2021 |
Oct 17, 2021 |
427: ACE2 downregulation following SARS-CoV-2 infection triggers dysregulation of RAAS and can lead to heart failure.
|
| 1924 |
Increased,Cardiac fibrosis
Short Name
Increased,Cardiac fibrosis
|
0 |
Organ |
Aug 19, 2021 |
Sep 1, 2021 |
550: Increased LMNA gene mutation leading to heart failure
|
| 1923 |
Altered gene expression, P53 dependent apoptosis pathway
Short Name
Altered expression of P53 pathway-dependent genes
|
0 |
Molecular |
Aug 19, 2021 |
Aug 19, 2021 |
419: Aryl hydrocarbon receptor activation leading to impaired lung function through P53 toxicity pathway
|
| 1922 |
Increased, Reactive metabolites production
Short Name
Increased, metabolites
|
0 |
Cellular |
Aug 19, 2021 |
Aug 26, 2021 |
417: Aryl hydrocarbon receptor activation leading to lung cancer through AHR-ARNT toxicity pathway
|
| 1921 |
Altered gene expression, NF-kB dependent Interleukin-6 pathway
Short Name
Altered expression of IL-6 pathway-dependent genes
|
0 |
Molecular |
Aug 19, 2021 |
Aug 19, 2021 |
2 AOPs
|
| 1919 |
Increased,Cardiac Dysregulation
Short Name
Increased,Cardiac dysfunction
|
0 |
Tissue |
Aug 18, 2021 |
Sep 1, 2021 |
None
|
| 1918 |
Increased,Myocardial apoptosis
Short Name
Increased,Myocardial apoptosis
|
0 |
Cellular |
Aug 18, 2021 |
Sep 1, 2021 |
None
|
| 1917 |
Altered gene expression, NRF2 dependent antioxidant pathway
Short Name
Altered expression of NRF2 pathway-dependent genes
|
0 |
Molecular |
Aug 17, 2021 |
Aug 19, 2021 |
3 AOPs
|
| 1916 |
Thromboinflammation, Increased
Short Name
Thromboinflammation, Increased
|
0 |
Organ |
Aug 4, 2021 |
Aug 4, 2021 |
412: Endothelial cell dysfunction leading to thromboinflammation
|
| 1915 |
Neutrophil activation, Increased
Short Name
Neutrophil activation, Increased
|
0 |
Cellular |
Aug 4, 2021 |
Aug 4, 2021 |
412: Endothelial cell dysfunction leading to thromboinflammation
|
| 1914 |
Platelet activation, Increased
Short Name
Platelet activation, Increased
|
0 |
Cellular |
Aug 4, 2021 |
Aug 4, 2021 |
412: Endothelial cell dysfunction leading to thromboinflammation
|
| 1913 |
Endothelial cell dysfunction
Short Name
Endothelial cell dysfunction
|
0 |
Cellular |
Aug 4, 2021 |
Aug 4, 2021 |
2 AOPs
|
| 1905 |
eya1 expression, inhibited
Short Name
eya1 expression, inhibited
|
0 |
Molecular |
Jul 14, 2021 |
Oct 7, 2021 |
410: GSK3beta inactivation leading to increased mortality via defects in developing inner ear
|
| 1904 |
six1b expression, increased
Short Name
six1b expression, increased
|
0 |
Molecular |
Jul 14, 2021 |
Aug 12, 2021 |
410: GSK3beta inactivation leading to increased mortality via defects in developing inner ear
|
| 1903 |
foxi1 expression, increased
Short Name
foxi1 expression, increased
|
0 |
Molecular |
Jul 14, 2021 |
Oct 28, 2021 |
410: GSK3beta inactivation leading to increased mortality via defects in developing inner ear
|
| 1902 |
Repression of Gbx2 expression
Short Name
Repression of Gbx2 expression
|
0 |
Molecular |
Jul 14, 2021 |
Oct 7, 2021 |
410: GSK3beta inactivation leading to increased mortality via defects in developing inner ear
|
| 1900 |
increased platelet surface TLR9 expression
Short Name
increased platelet tlr9 expression
|
0 |
Cellular |
Jul 8, 2021 |
Jul 8, 2021 |
377: Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Multi Organ Failure involving Acute Respiratory Distress Syndrome (ARDS)
|
| 1899 |
formation of neutrophil extracellular traps (NETs)
Short Name
NETosis
|
0 |
Cellular |
Jul 8, 2021 |
Jul 8, 2021 |
377: Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Multi Organ Failure involving Acute Respiratory Distress Syndrome (ARDS)
|